" class="no-js "lang="en-US"> MayaMD - Medtech Alert
Tuesday, September 23, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
MayaMD | Pharmtech Focus

MayaMD

About MayaMD

MayaMD

MayaMD.Ai provides advanced healthcare solutions for a digital world. Our mission is to help minimize the risk of diagnosis error. Our MayaMD.Ai personal health assistant app is the most advanced and sophisticated diagnosis and clinical decision support tool available. Download our app today and receive the most advanced healthcare insight and information available.

Related Story

Artificial Intelligence

 MayaMD & LG Electronics Offer New AI Healthcare at Home Program Via Smart TV | Pharmtech Focus

MayaMD & LG Electronics Offer New AI Healthcare at Home Program Via Smart TV

February 14 2022

MayaMD, one of LG NOVA’s Proto Challenge first winners, will offer its AI health assistant […]